mRNA

Our team of experts at NorthX Biologics optimizes every stage of the mRNA process development. We strive for maximum yield and purity, ensuring that your mRNA therapeutics are manufactured efficiently and to the highest standards.

NorthX Biologics offers IVT services up to 5L in our standard platform, providing scalability to meet your production needs. Our rigorous process ensures high-quality mRNA products, optimized for downstream applications.

We provide co-transcriptional or enzymatic capping services to ensure stability and efficient translation of your mRNA products. This essential modification plays a key role in mRNA stability and protein translation efficiency.

Our team is skilled in LNP formulation, an essential step for the effective delivery of mRNA therapeutics. We design and optimize LNPs to enhance mRNA stability and promote efficient delivery to target cells.

NorthX Biologics is capable of producing mRNA products suitable for both GMP and R&D applications. Regardless of the scale and purpose of your project, we maintain the highest standards of quality and consistency.

We provide aseptic fill/finish services to ensure your mRNA products are appropriately packaged and ready for distribution. Our aseptic processes are designed to maintain the integrity and quality of your product, preparing them for successful clinical use.

At NorthX Biologics, we understand the importance of comprehensive and aligned phase-appropriate analytics. We provide robust analytical services to track the progress of your product throughout its development and production stages, ensuring consistent quality and regulatory compliance.